The American Medical Association reports that about 30 million people in the US live with sleep apnea, but only one-fifth of these cases are clinically diagnosed. That means that many people are ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Nearly 30 million adults in the U.S. have obstructive sleep apnea (OSA)-and many don't even know it. If you've been waking up exhausted or dealing with unexplained headaches, your body might be trying ...

Around 30 million people in the U.S. suffer from the disease, according to the American Lung Association, but millions go undiagnosed.

Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea. The agency ...

Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep. The ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition will regularly stop breathing during sleep as the muscles in their throat ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone calls earlier this year after the Food and Drug Administration approved ...

Please Note: This is a guest post that is presented for informational purposes only and is not meant to diagnose or treat any illness. If you have any health concern, see a licensed healthcare ...

The telltale symptoms of sleep apnea may look different in older people, recent research suggests.

The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity. Reading time 3 minutes Many people struggling with apnea will now have a new way ...